DEFINITIVE PROXY STATEMENT

Company

Actinium Pharmaceuticals, Inc.

Filed

November 12, 2015

Period of Report

October 16, 2015

Accession Number

0001213900-15-008502

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →